NYSE · Health Care · Drug Manufacturers - General
MRK
Merck & Co., Inc.
Sells vaccines, animal health products and prescription drugs, with profits concentrated in one cancer immunotherapy nearing patent expiry.
$135.84+0.21%
Close · 2026-08-14$80$100$120
NovFebMayAug
$75.81
$135.9752-week range, last close at 100% of the range
- 1W
- +5.65%
- 1M
- +9.89%
- 3M
- +22.84%
- 6M
- +13.52%
- YTD
- +30.94%
- 1Y
- +69.62%
- Avg vol 20d
- 8.1M
- RVOL
- 0.56
- HOLD band
Fundamentalsas of 2026-08-14
- Mkt cap
- $335.14B
- P/E
- 108.7
- Fwd P/E
- 14.2
- EPS
- $1.25
- Div yield
- 2.50%
- Beta
- 0.21
- Employees
- 73K
- Next earnings
- 2026-10-29
Rating & verdict historyoldest → newest
0.0% correct+1.82% avg moveBUY 0/0 · HOLD 0/1 · SELL 0/0
| Date | Call | Outcome | Return | Takeaway |
|---|---|---|---|---|
| 2026-08-14 | Subscribers | — | — | Subscribe to read |
| 2026-08-13 | Subscribers | — | — | Subscribe to read |
| 2026-08-12 | Subscribers | — | — | Subscribe to read |
| 2026-08-11 | Subscribers | — | — | Subscribe to read |
| 2026-08-10 | Subscribers |